Missing the Benefit of Metformin in Acute Myeloid Leukemia: A Problem of Contrast?

OBJECTIVE: To evaluate whether metformin's cancer-related benefits reported in patients with solid tumors (ST) are also present in acute myeloid leukemia (AML) patients. METHODS: Baseline demographic and clinical history for all diabetes mellitus patients newly diagnosed with AML or cancer of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceacareanu, Alice C., Nimako, George K., Wintrob, Zachary A. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632934/
https://www.ncbi.nlm.nih.gov/pubmed/29026839
http://dx.doi.org/10.4103/jrpp.JRPP_17_37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632934/
https://www.ncbi.nlm.nih.gov/pubmed/29026839
http://dx.doi.org/10.4103/jrpp.JRPP_17_37

Ejemplares similares